China Isotope Radiation Corporation
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services and Other Businesses segment provides independent clinical laboratory services for nuclear technology industry applications and medical product applications. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation. Show More...
-
Website https://www.china-isotope.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 12.72 HKD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CNY 0.79 0.82 1.13 1.15 1.03 1.03 Dividends CNY 0.15 0.12 0.12 Payout Ratio % * 24.7 11.9 Shares Mil 320.0 320.0 240.0 279.0 320.0 320.0 Book Value Per Share * HKD 6.85 12.4 12.75 Free Cash Flow Per Share * HKD 0.38 -0.89 Return on Assets % 8.56 8.0 6.56 5.59 4.19 4.19 Financial Leverage (Average) 3.5 3.86 2.51 1.98 2.35 2.35 Return on Equity % 29.99 29.53 19.41 12.1 9.1 9.1 Return on Invested Capital % 28.27 23.08 15.4 11.11 7.39 7.39 Interest Coverage 55.16 39.58 81.35 90.41 40.12 40.12 Current Ratio 1.5 1.32 1.81 2.21 1.93 1.93 Quick Ratio 1.27 1.14 1.57 1.96 1.69 1.69 Debt/Equity 0.07 0.08 0.04 0.17 0.17